US$ 22.53
dihexa long-term safety data AngIV-Analog Rescues Cognitive Impairment and Recovers Memory in the APP/PS1 Mouse via the PI3K/AKT Signaling Pathway Pathway-based network medicine identifies novel
Description
How long until KLOW is expected to show changes in research

Ongoing trials with angiogenesis inhibitors in ES-SCLC

[DOI] [PubMed] [Google Scholar] 62.Sucic M., Luetic K., Jandric I., Drmic D., Sever A.Z., Vuletic L.B., Halle Z.B., Strinic D., Kokot A., Seiwerth R.S., et al

BMJ 354 , i3518 (2016)
